Antivirals for influenza: strategies for use in pediatrics.
Influenza infection is annually responsible for significant morbidity and mortality, particularly among the very young and old. Recently updated guidelines recommend influenza vaccination of all children aged 6 months to 18 years; however, childhood vaccination remains underutilized. Furthermore, concerns over the reduced efficacy of vaccination in children have further heightened the need for effective treatment schemes. Antiviral therapies have emerged as attractive options in the battle against influenza infection. These agents include the adamantanes (amantadine and rimantadine) and neuraminidase inhibitors (zanamivir, oseltamivir, and peramivir). Broad-scale use of adamantane antivirals has been severely limited in recent years because of high resistance rates and their inability to cover influenza type B. Neuraminidase inhibitors cover influenza types A and B, and have been promulgated to first-line therapy because of historically low resistance rates and relatively infrequent side effects. Moreover, these agents are effective options in combating non-seasonal influenza strains, including H5N1 and pandemic 2009 H1N1. Oseltamivir may be particularly appealing for treating children since it is available in multiple oral dosage formulations, whereas commercially available zanamivir use is limited in young children because it requires inhalation. However, the emergence of resistance to oseltamivir among influenza A strains may limit its usefulness. Additional concerns with neuraminidase inhibitor use in pediatrics center around emerging reports, primarily from Japan, that have temporally linked oseltamivir to significant neuropsychiatric events in children of varying ages. Numerous novel antiviral agents are under development, but most are far from market approval. In addition to treating and preventing the initial burden of pediatric influenza infection, antiviral therapies may significantly reduce secondary bacterial infections (including pneumonia and otitis media), unnecessary antibiotic prescribing, and healthcare-associated costs.
Smith
Steven M
SM
Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA. ssmithm@ufl.edu
Gums
John G
JG
D000218:Adamantane / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D009975:Orthomyxoviridae / Q000187:drug effects / Q000201:enzymology; D010372:Pediatrics / Q000379:methods*
D000998:Antiviral Agents; D009439:Neuraminidase; D000218:Adamantane
MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60
18685555
Pediatr Int. 2002 Feb;44(1):43-6
11982870
J Infect Dis. 2006 Nov 1;194 Suppl 2:S133-8
17163386
J Infect Dis. 2004 Oct 15;190(8):1369-73
15378427
N Engl J Med. 2000 Nov 2;343(18):1282-9
11058672
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8682-6
15173583
Antimicrob Agents Chemother. 2003 Aug;47(8):2518-25
12878514
Semin Respir Infect. 1992 Mar;7(1):26-37
1609165
JAMA. 2006 Feb 22;295(8):891-4
16456087
MMWR Recomm Rep. 2007 Jul 13;56(RR-6):1-54
17625497
Antiviral Res. 2000 Jul;47(1):1-17
10930642
N Engl J Med. 2005 Sep 29;353(13):1363-73
16192481
Antimicrob Agents Chemother. 2004 Dec;48(12):4855-63
15561867
CMAJ. 2003 Jan 7;168(1):49-56
12515786
MMWR Morb Mortal Wkly Rep. 2007 Sep 21;56(37):963-5
17882126
Antimicrob Agents Chemother. 2006 Apr;50(4):1470-9
16569867
Antiviral Res. 2007 Nov;76(2):186-93
17719657
MedGenMed. 2007 Oct 30;9(4):23
18311373
Pediatr Infect Dis J. 2001 Feb;20(2):127-33
11224828
Antiviral Res. 2008 Dec;80(3):266-71
18601954
Lancet. 1998 Dec 12;352(9144):1877-81
9863784
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002745
18254006
Lancet. 2006 Jan 28;367(9507):303-13
16443037
Pediatrics. 2008 Apr;121(4):e1016-31
18381500
Toxicol Appl Pharmacol. 1969 Nov;15(3):642-65
4982107
N Engl J Med. 2000 Dec 14;343(24):1778-87
11114318
J Med Virol. 1987 Mar;21(3):249-55
3549971
Can J Infect Dis. 2000 Nov;11(6):295-8
18159303
J Pediatr. 2006 Dec;149(6):755-762
17137887
Pediatr Int. 2005 Aug;47(4):484
16091087
Tohoku J Exp Med. 2008 Feb;214(2):129-38
18285670
Clin Infect Dis. 2010 Jun 1;50(11):1493-6
20415572
Clin Infect Dis. 2008 Aug 1;47(3):339-45
18582202
N Engl J Med. 2005 Dec 15;353(24):2559-67
16354892
Jpn J Tuberc Chest Dis. 1971 Jul;17(1):1-7
4948478
N Engl J Med. 2000 Mar 2;342(9):661-2
10702061
Antimicrob Agents Chemother. 1999 Jul;43(7):1616-20
10390212
Antimicrob Agents Chemother. 2007 Mar;51(3):845-51
17194832
Pediatr Infect Dis J. 2008 Aug;27(8):738-43
18664986
MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):404-9
18418347
Pediatr Int. 2003 Jun;45(3):366-7
12828601
MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40
15163927
Pediatr Infect Dis J. 2010 Mar;29(3):195-8
19949363
Antiviral Res. 2006 Jan;69(1):39-45
16325932
Eur J Clin Microbiol Infect Dis. 2000 Nov;19(11):834-42
11152308
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8676-81
15173599
Antivir Ther. 2003 Jun;8(3):183-90
12924534
J Antimicrob Chemother. 2003 Jan;51(1):123-9
12493796
Pediatrics. 1987 Aug;80(2):275-82
3302925
Jpn J Tuberc Chest Dis. 1968 Dec;15(1):17-26
4906644
Lancet. 2009 Oct 17;374(9698):1312-3
19837238
Expert Opin Pharmacother. 2008 Feb;9(2):151-61
18201141
Lancet. 2005 Oct 1;366(9492):1175-81
16198766
JAMA. 2007 Apr 4;297(13):1435-42
17405969
BMJ. 2007 Jun 16;334(7606):1232-3
17569896
J Infect. 2000 Jul;41(1):73-83
10942644
Drug Saf. 1999 Oct;21(4):267-81
10514019
Lancet. 1971 Jul 17;2(7716):113-5
4104457
Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92
18625765
BMJ. 2009 Aug 10;339:b3172
19666987
Antimicrob Agents Chemother. 2004 Dec;48(12):4542-9
15561823
Antiviral Res. 2005 Oct;68(1):10-7
16087250
N Engl J Med. 2010 Jan 7;362(1):88-9
20032317
Pediatr Infect Dis J. 2000 May;19(5):410-7
10819336
Antiviral Res. 2008 Apr;78(1):91-102
18328578
Clin Infect Dis. 2007 Dec 15;45(12):1568-75
18190317
Pharmacoeconomics. 1996;9 Suppl 3:26-33; discussion 50-3
10160483
Emerg Infect Dis. 2009 Apr;15(4):552-60
19331731
J Infect Dis. 2004 Feb 1;189(3):440-9
14745701
N Engl J Med. 2007 Feb 15;356(7):685-96
17301299
Cell. 1992 May 1;69(3):517-28
1374685
J Am Chem Soc. 1997 Jan 29;119(4):681-90
16526129
J Virol. 1994 Mar;68(3):1551-63
7508997
Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13
19067613
Pediatrics. 2007 Mar;119(3):e587-95
17332179
Clin Infect Dis. 2008 Sep 15;47(6):735-43
18694344
Nature. 1983 May 5-11;303(5912):35-40
6843658
Pediatr Infect Dis J. 2005 Jun;24(6):575-6
15933579
Respir Res. 2006 Mar 23;7:43
16553963
Epidemiology. 2009 Jul;20(4):619-21
19367165
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1240-9
20516360
Paediatr Drugs. 2001;3(3):229-36
11310719
JAMA. 2009 Mar 11;301(10):1042-6
19255111
JAMA. 2000 Feb 23;283(8):1016-24
10697061
Drug Saf. 1998 Sep;19(3):233-41
9747669
BMJ. 2007 Jul 14;335(7610):59
17626921
Infect Dis Clin North Am. 1987 Jun;1(2):441-57
3332797
Clin Infect Dis. 1998 Jun;26(6):1418-24
9636873
JAMA. 2004 Sep 15;292(11):1333-40
15367555
Annu Rev Med. 2008;59:397-413
17939760
Virology. 1991 Feb;180(2):617-24
1989386
Nat Rev Drug Discov. 2007 Dec;6(12):967-74
18049471
Drug Saf. 2008;31(12):1097-114
19026027
N Engl J Med. 2007 Oct 4;357(14):1450-1
17914053
N Engl J Med. 2010 May 6;362(18):1708-19
20445182
Pharmacotherapy. 2006 Jan;26(1):95-103
16506351
N Engl J Med. 2000 Jan 27;342(4):225-31
10648763
J Infect Dis. 2007 Nov 15;196(10):1493-9
18008229
Am J Manag Care. 2000 Feb;6(2):205-14
10977420
N Engl J Med. 2008 Oct 9;359(15):1555-64
18799552
Am J Psychiatry. 2007 Jun;164(6):870-6
17541044
Pediatr Infect Dis J. 2010 Jun;29(6):495-8
20035245
Antivir Ther. 1996 Jan;1(1):51-6
11322259
BMJ. 2003 Jun 7;326(7401):1235
12791735
Arch Intern Med. 2003 Jul 28;163(14):1667-72
12885681
J Infect Dis. 2010 Aug 15;202(4):563-6
20594104
Lancet. 2004 Aug 28-Sep 3;364(9436):759-65
15337401
J Virol. 1996 Dec;70(12):8391-401
8970960
Lancet. 2000 May 27;355(9218):1845-50
10866439
Antiviral Res. 2006 Jul;70(3):121-31
16516984
J R Coll Gen Pract. 1973 Jan;23(126):34-7
4574716
JAMA. 2003 Jan 8;289(2):179-86
12517228
Pediatr Int. 2004 Apr;46(2):122-5
15056235
Pediatrics. 2005 Jul;116(1):153-9
15995046